Phenotypic characterization and mapping of more than 50 Mal-mutations located in the malB region lead one to divide the site for Mal-Xs mutations (formerly called gene ma1B) in that region, into two adjacent genetic segments maU and malK. magl and malK are both involved in maltose permeation. It is suggested that (i) malK and lamB, the only known gene specifically involved in phage X adsorption (20), constitute an operon of' polarity malK lamB. (ii) mal and malK correspond to two different genes, and (iii) a promoter for the malK lamB operon is located between maJ and malK. Since X receptors and maltose permease are inducible by maltose and absent in malT mutants, it is likely that the expression of the malK lamB operon is controlled by the product of' gene malT, the positive regulatory gene of the maltose system.
In wild-type Escherichia coli K12 maltose induces the three enzymatic activities responsible for its assimilation as well as the bacterial receptor sites for phage X (17, 21) . All the known genes specifically implicated in maltose metabolism and in phage X receptor synthesis are located in either of two regions of the genetic map: malA and malB ( Fig. 1) (15, 20) .
The malA region contains an operon composed of malP and malQ the structural genes for maltodextrin phosphorylase and amylomaltase, and a positive regulatory gene malT (3, 4, 16, 18) . The activator protein, product of malT, allows expression of the malP malQ operon in the presence of maltose. The target for this control is the malI locus (or initiator) located, like the promoter of the malP malQ operon, between genes malP and malT ( Fig. 2 ) (7, 8) .
The structure of the malB region is less well known. Mutations affecting this region can be classified according to three phenotypes: Mal+Xr, Mal-As, Mal-Ar. It was earlier proposed that Mal+Xr mutations affect a gene lamB involved in X receptor synthesis but not in maltose metabolism, that Mal-Xs mutation affect another gene malB involved in maltose permeation, and that Mal-Xr mutations affect both genes. (It is now known [this paper and M. Hofnung, Genetics, submitted for publication] that there is more than one gene of the malB region which is involved in maltose permeation. However, we still call here gene malB [or simply malB] the cluster of genes in the malB region defined by Mal-Xs mutations; the malB region 40 includes thus genes malB and lamB). Some of' the Mal-Xr mutations revert. They were assumed to be polar mutations and their existence was tentatively taken as evidence that the malB gene and the lamB gene belong to a single operon. In addition, to account for the inducibility of' the activities encoded by the malB region, as well as for their absence in malT mutants, it was assumed that the operon in the malB region was like the malP malQ operon in the malA region-subject to malT gene control (17, 20) .
A more detailed genetic analysis of the malB region appeared to be of' interest not only from the point of' view of' positive regulation but also because it could contribute to the understanding of two functions of' the cell envelope, active transport, and phage adsorption, and of possible relations between them. Studies of Mal+Xr mutations allowed one to propose that lamB was a single cistron (20) . The characterization of Mal-As and Mal-Ar mutations reported in this paper suggests that more than one gene of' the malB region may be involved in the permeation of' maltose and that this region is more complex than f'irst thought.
MATERIALS AND METHODS
Strains. Bacterial strains are listed in Table 1 . Xv is a virulent mutant of phage A (10). The P1 strain used is a partially virulent mutant of Plkc obtained from S. Brenner. Genetic nomenclature is that of Taylor and Trotter (19) . The abbreviations for phenotypes are as follows: Ar (As) means resistant (sensi-tive) to a virulent mutant of A. Mal+(Mal-) means able (unable) to use maltose as a carbon source.
Media and techniques. Media (3, 4, 15) techniques for transduction (8) , conjugation on plates and in liquid (3) ethyl methane sulfonate (EMS) N-methyl-N'-nitro-N-nitrosoguanidine (NTG) and UV (16) mutagenesis, enzyme assays, detection of amylomaltase activity on plate (8) and screening of Malnonsense mutants (4) were already described. It should be recalled that no analogue of maltose that is a substrate of the permease but is not further metabolized is yet available. Therefore, the permease assay measures both the uptake and subsequent metabolism of "C-maltose.
Isolation of Mal-As mutants with lesions in the malB region. Among 84 independent Mal-mutants isolated from strain HfrG6 on eosin methylene blue (EMB) or tetrazolium (TTZ) maltose agar after EMS mutagenesis, 65 were shown to have a lesion in the malA region (3, 4 (Table 2) .
Three other As malB mutations malK2, malK5, and maIJ4, obtained in a slightly different way have been added to this study. malK2 and malK5, formerly called MB10 and MPE2, were isolated in strain HfrG6 after ultraviolet (UV) mutagenesis (16) . Mutation maUJ4, formerly called MB4, was isolated in strain HfHU482 after NTG treatment (16) .
Isolation of Mal Ar mutants with lesions in the malB region. Ar malB mutants of strain HfrG6 express the malP malQ operon in a constitutive way (M. Schwartz, Ph.D. thesis, Univ. of Paris, 1967; 20) . They were isolated as follows. Spontaneous Ar mutants were first selected from independent cultures of strain HfrG6 (17) and then plated on M63 Bi his (thiamine-histidine) agar medium containing glucose as a carbon source (8) . The developed plates were replicated on M63 Bi his agar medium containing glycerol as a carbon source (8) where the colonies with constitutive amylomaltase activity were detected as already described (8) . The corresponding colonies from the master plate were then reisolated. The mutations obtained in this way were designated malK100 to malK106 (revertible) or MalBA (nonrevertible) ( Table 3) .
Search for spontaneous Mal+ derivatives of malB mutants. Isolated colonies of the malB mutant were inoculated in a flask with 500 ml of ML medium (3) and grown to saturation. A 100-ml amount of the culture was then centrifuged, the pellet was resuspended in 2 ml of M63 medium, and samples were plated on eosine methylene blue minimal (EM) maltose agar medium supplemented with B, and histidine. When the malB mutant was Ar, 10 to 50 Mal+ derivatives were tested for sensitivity to A.
Recombination studies. Recombination studies were performed by HfrxF-and F'xF-crosses. It was assumed that the Mal Ar nonrevertible mutations designated malBA were deletions. They were introduced into an F-strain and tested for recombination with all the malB mutations (malJ, malK, and malBA). Mutations malKlOO to malK106 were treated like the malBA mutations. The malB Fstrains used were argH+ metA+ malB thr leu his+ str (7, 8) . The structure of the malB region is discussed in this paper and in M. Hofnung, Genetics, submitted for publication.
VOL. 117, 1974 41 Fig. 4 were transferred on the KLF12 episome as described in (M. Hofnung, Genetics, submitted for publication). The resulting malB episome were then introduced into a series of F-strains carrying the different malB mutations and tested for recombination. The episome KLF10 carrying a Mal-Ar mutation named malB15 (1) was used in a similar way to carry out mapping studies. Episome KLF10 was isolated from HfrJ4 (11) (also called HfrP1O [1] ) in which the F' factor is integrated in the malB region (16) .
F' x F-crosses were performed by a rapid procedure described in reference (M. Hofnung, Genetics, submitted for publication). F-strains were argH malB his str. The F' factors were carried by a strain harboring on its chromosome the markers argH malBA101 recA thyA (M. Hofnung, Genetics, submitted for publication). In the cases when recombination to Mal+ occurred, two recombinants were isolated and were shown to have the expected genetic characteristics. The F' x F-crosses had approximately the same resolving power as the Hfr x F-crosses and gave identical results which were compatible with the order of markers established by three-point tests (Table 4) .
Three mutations, malK106, mal"J5" and mal "J9", (Tables 2 and 3) have not been represented on the genetic map (Fig. 4) > 00
a Column 2: order of' magnitude of' the average frequency of' Mal+ derivatives determined from at least three independant cultures of' each mutant. The frequency of' Mal+Ar derivatives is approximately the same for all the mutants, revertable or not, in which it was tested. This is to be exprected if the Mal+Ar derivatives are due to a suppressor independant of' the original malB mutation (see Discussion). This frequency was ranging f'rom 10'-to 10-'°. For comparison the frequency of' Mal+ derivatives of' strain HfrG6 malK1 was about 108 of strain HfrG6 ma/J11 about 10', and strains HfrG6 mal"J5" and HfrG6 mal"J9" between 10'9 and 10" Column 3: the values reported for malK100 and malKi01 are the extreme values found in at least three independant cultures of' the mutants. (17) . In strains diploid for the malA region most Mal-Ar mutants have lesions in the malB region (20) . All such Ar malB mutants isolated in a derivative of strain HfrG6 diploid for the malA region were shown to express the malP malQ operon in a partially constitutive way (20) .
Mal+ lamB mutants were never found to express the malP malQ operon in a constitutive way (20 Paris, 1967.) Genetic map. Three markers in the malB region had previously been mapped with respect to one another and to the neighboring genes metA and uurA (Fig. 3) (16) . A more detailed map (Fig. 4) of' the region has now been constructed by a deletion mapping procedure based on the assumption that the Ar malB non revertible mutations were deletions (see Materials and Methods). This map has been oriented with respect to the neighbouring genes by ordering the markers metA, malK101, ma/K2, and malK105 using three-point tests (Table 5 and Fig. 4) .
Examination of' the map (Fig. 4) calls for the following observations: (i) the Ar malB nonrevertible mutations (named malBA) are indeed deletions. Each of these mutations is unable to recombine with at least two recombining mutations. The Mal-Ar mutation of episome KLF10 also behaves like a deletion. There is a preferential region for the left end of' the deletions, between malK3 and malK4 (Fig. 4) . The seven deletions (out of' 23) ending in this region cover also the site of' integration of' the F factor of' HfrPlO. ( ii) The malB gene defined as the site for Mal-As mutations in the malB region can be divided into two segments according to the level of' expression of' the malP malQ operon promoted by the mutations they contain. Mutations on the metA side of'the malB gene (class I) result in a basal or slightly above basal level of' expression of' the malP malQ operon (Table 2) . Mutations on the uurA side (class II) lead to a partially constitutive level of' expression of' the malP malQ operon (Table 2) . We call the two segments mag and malK, respectively. (iii) The reverible Mal-Ar mutations (malKI00 to malK105) behave as mutations of the malK segment: they lie between the last mutations at the right of' the ma/ segment and the last mutations at the right of' the malK segment (ma/K4 and malK5) and promote a constitutive expression of' the malP malQ operon (Table 3) . -I-I. a Reciprocal three-point tests used to orient the malB region with respect to neighbouring markers. Order of markers is: argH, metA, malKlOl, malK2, malK105 (see also Fig. 4) . The tests were performed by conjugation. The donor strains were malB derivatives of strain HfrG6 (His-). The recipients were F-strains carrying malB mutations and the markers argH and metA (Table 1) .
tions are located inside the malK segment.
This fact is in agreement with the hypothesis that mutations in the malB gene can inactivate the lamB activity by polarity.
None of these supposedly polar mutations can be shown to be located entirely within the maLIJ segment. In other words, abolition of the lamB activity by such mutations seems to require that the site of the mutation extends into the malK segment. This is an argument which, although negative, suggests that there is a barrier for polarity between the mag and malK segments. The possible nature of such a barrier will be examined in the discussion. (20) . All this agrees with the hypothesis that the malK segment and gene lamB belong to the same operon with polarity exerted from malK to lamB. However, it remains to be proved that the malK segment and lamB are indeed different cistrons.
The order of the markers in the malB region is metA ... malJ segment -malK segment -lamB ... uvrA (Fig. 4) . The fact that all the (8) . The other suppresses a defect in lactose entry as well as in maltose entry and could operate through a nonspecific change in the permeability of' the cell envelope (12) .
The revertible Ar mutations (malKO00 to malK105) all occur in malK and inactivate gene lamB in cis position. They are spontaneous mutations and revert, although at different rates. None of them is suppressible by suIlI or suIV. Such mutations could be due to insertions of the type already described (6, 14) which are known to exert a strong polar effect on the expression of all distal genes in the same unit of transcription.
Expression of the malJ and malK segments. One may try to define more accurately to which functional genetic structure the mali and malK segments correspond. Do they specif'y a single protein involved in maltose metabolism and consisting of two regions having different enzymatic activities (9, 13)? Or do they code for two different polypeptide chains both playing a role in maltose entry? In other words, do they correspond to a single gene or to two genes? Two independant arguments encourage us to favor the latter hypothesis. First, if the product of the mag and malK segments were a single polypeptide chain, the polarity of' transcription of the mai1 segment should be the same as that of the malK segment: i.e., one should have the polarity exerted from the mal segment to the malK segment to the lamB gene. Then, nonsense mutants in the maW segment would be totally devoid of the activity corresponding to the malK segment and would result in a constitutive expression of the malP malQ operon as do deletions entering both mali and malK. As this is not the case (Table 2) one is led to think that nonsense mutants in the mag segment possess some malK segment activity. This is possible only if there is some initiation of' translation, transcription or both between the mali and the malK segments. Second, it was suggested above, that there is a barrier for polarity between the malJ and malK segments so that mutations located entirely within mal cannot exert a polar effect on lamB expression. An initiation point for translation alone could not account for such a barrier since it should not be able to prevent all mutations inside makJ from being polar for lamB expression. Those two arguments lead one to suggest that there is a promoter for the malK lamB operon between the maliJ and malK segments. We therefore propose the hypothesis that the mal and malK segments correspond to two genes which we name mali and malK and that a promoter for the malK lamB operon is located between mali and malK. Such proposals are further sustained by complementation data to be published (M. Hofnung, Genetics, submitted for publication). Since the maltose permease and X receptor sites are inducible by maltose, and absent in malT mutants, we suggest that the activator regulates the expression of' the malK lamB operon. It cannot be said however what the direction of' transcription of the mali gene is or whether its expression is inducible or not. Further genetic analysis of' the malB region and biochemical characterization of' its products is necessary to test the hypothesis presented and to describe more precisely the mode of' expression of' the makl gene.
